Get started
Innocan Pharma Corp.Innocan Pharma Corp.Innocan Pharma Corp.

Innocan Pharma Corp.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals

INNPF chart

Key stats

Market capitalization
‪52.84 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.0186USD
Net income (FY)
‪−4.79 M‬USD
Revenue (FY)
‪13.91 M‬USD
Shares float
‪203.51 M‬
Beta (1Y)
0.00

About INNOCAN PHARMA CORPORATION

Sector
Health Technology
CEO
Iris Or Gabi Bincovich
Headquarters
Calgary
Website
innocanpharma.com
Employees (FY)
9
Founded
2018
FIGI
BBG00YB9B2M2
InnoCan Pharma Corp. operates as a pharmaceutical tech company. Its segments include: Pharmaceuticals and Consumer Wellness. The Pharmaceuticals segment focuses on developing innovative drug delivery platform technologies based on advanced cannabinoids science. It involves two drug delivery technologies: LPT CBD- loaded liposome platform and CLX CBD-loaded exosomes platform. The Consumer Wellness segment develops and markets a wide portfolio of innovative and self-care products to promote a healthier lifestyle. The company was founded in October 2017 and is headquartered in Alberta, Canada.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of INNPF is 0.1995 USD — it has decreased by 4.13% in the past 24 hours. Watch Innocan Pharma Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Innocan Pharma Corp. stocks are traded under the ticker INNPF.
INNPF stock is 4.31% volatile and has beta coefficient of 0.00. Track Innocan Pharma Corp. stock price on the chart and check out the list of the most volatile stocks — is Innocan Pharma Corp. there?
Yes, you can track Innocan Pharma Corp. financials in yearly and quarterly reports right on TradingView.
INNPF stock has fallen by 4.18% compared to the previous week, the month change is a 13.67% fall, over the last year Innocan Pharma Corp. has showed a 39.51% increase.
INNPF net income for the last quarter is ‪−907.40 K‬ USD, while the quarter before that showed ‪−2.00 M‬ USD of net income which accounts for 54.66% change. Track more Innocan Pharma Corp. financial stats to get the full picture.
Today Innocan Pharma Corp. has the market capitalization of ‪52.84 M‬, it has decreased by 2.43% over the last week.
No, INNPF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, INNPF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Innocan Pharma Corp. stock right from TradingView charts — choose your broker and connect to your account.
INNPF reached its all-time high on Sep 16, 2021 with the price of 1.2706 USD, and its all-time low was 0.1420 USD and was reached on Apr 17, 2023. View more price dynamics on INNPF chart.
See other stocks reaching their highest and lowest prices.
As of May 6, 2024, the company has 9.00 employees. See our rating of the largest employees — is Innocan Pharma Corp. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Innocan Pharma Corp. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Innocan Pharma Corp. stock shows the strong sell signal. See more of Innocan Pharma Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Innocan Pharma Corp. EBITDA is ‪−3.84 M‬ USD, and current EBITDA margin is −27.60%. See more stats in Innocan Pharma Corp. financial statements.